A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report, European Journal of Hospital Pharmacy
Portuguese study reported a greater incidence of adverse drug reactions with hydroxychloroquine vs remdesivir (n=149; total of 102 events; 47.5% vs 12.5%; p
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: COVID-19 | Drugs & Pharmacology | Health | Hospitals | Hydroxychloroquine | Portugal Health | Study